Delivery Order SPE2DB20D2002-SPE2DB22FL20H
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,568.68 for the supply of 4,556,952,350 units of Verapamil ER 240 mg tablets. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Verapamil ER 240 mg tablets. The $11,716.28 firm-fixed-price delivery order was made under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $86,810.82 contract is for the delivery of 500 bottles of the pharmaceutical product Verapamil ER 240 mg tablets. It was awarded as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. The award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,205.76 firm fixed-price delivery order is for the supply of 100 units of Verapamil ER 120 mg tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award, with the ID SPE2DB22D3004|SPE2DB24FNR28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,245.54 firm-fixed-price delivery order is for the supply of 4,563,045,475 units of Verapamil SR 240 mg capsules, a medication used to treat cardiovascular conditions. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, number SPE2DB20D2002|SPE2DB22FL09P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,205.37 delivery order is for the supply of 4,555,797,600 Verapamil ER 120 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical through November 2026. The IDC enables the company to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Verapamil 120 mg tablets. The $1,556.08 firm fixed-price contract has a completion date of June 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.58 Firm Fixed Price Delivery Order covers the provision of VERAPAMIL ER PM 300 MG CAPSULE 100S, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $7,289.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,116,078 units of the drug Verapamil ER PM 300 mg capsules, with an ultimate completion date of May 5, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. The contract is for the supply of 4,561,697,406 units of Verapamil ER 240 mg tablets, a medication used to treat high blood pressure and certain heart conditions. The order has a ceiling value of $7,564.88 and a completion date of August 7, 2023. Amerisourcebergen is the child company of Cencora, Inc., which holds a larger...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL20HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,280.64 firm fixed-price delivery order is for the supply of 4556274166 - Verapamil ER 240 mg Tablets in 100-count bottles. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable the efficient government procurement of essential pharmaceuticals and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/15/22 |